iShares U.S. Medical Devices ETF Technicals
iShares U.S. Medical Devices ETF logo

iShares U.S. Medical Devices ETF(ALLUS_IHI)

$53.05-0.06%

Market is closed - opens 7 PM, 30 May 2023

Insights

  • iShares U.S. Medical Devices ETF is currently not in a favorable trading position ( SELL ) according to technical analysis indicators.
  • Based on analysis of the Oscillators technical indicator, the current market trend for iShares U.S. Medical Devices ETF stock suggests that it is range bound and no decision can be made based on this information
  • Based on analysis of the Moving Averages technical indicator, iShares U.S. Medical Devices ETF stock is Range bound.
  • Based on analysis of the Pivot Points, the current market trend for iShares U.S. Medical Devices ETF stock suggests that it is a good time to sell or bad time to initiate a fresh position

Analysis Summary

Oscillators

Sell

Neutral

Buy

Moving Averages

Sell

Neutral

Buy

Pivots

Sell

Neutral

Buy

Oscillators

Name

Value

Action

Relative Strength Index
43.67
Neutral
Stochastic
8.95, 11.22
Neutral
Ultimate Oscillator
36.84
Neutral
Stochastic Relative Strength Index
0.0, 3.43
Neutral
Moving Average Convergence Divergence
-0.42, -0.05
Neutral

Moving Averages

Simple Moving Average

Period (Days)

Value

Action

10
54.61
Sell
20
55.29
Buy
50
54.73
Buy

Exponential Moving Average

Period (Days)

Value

Action

10
54.33
Sell
20
54.84
Buy
50
54.7
Buy

Volume Weighted Moving Average

Period (Days)

Value

Action

10
54.3
Neutral
20
55.08
Neutral
50
54.93
Neutral

Double Exponential Moving Average

Period (Days)

Value

Action

10
53.5
Sell
20
54.43
Sell
50
55.38
Buy

Triple Exponential Moving Average

Period (Days)

Value

Action

10
53.07
Sell
20
53.67
Sell
50
55.26
Sell

Pivot

Pivot

Value

Resistance L3
53.92
Resistance L2
53.7
Resistance L1
53.37
Pivot Point
53.15
Support L1
52.82
Support L2
52.6
Support L3
52.27

*Disclaimer: The content present here is for informational purposes only, you should not construe any such information or other material as investment advisory.